Table 1.
Comparison of baseline characteristics between IMN patients and healthy controls.
| Clinical characteristics | Healthy control | IMN patients |
||
|---|---|---|---|---|
| Stage I | Stage II | Stage III + IV | ||
| Number (n) | 189 | 162 | 130 | 72 |
| Age (years old) | 47.28 ± 9.74 | 46.85 ± 10.68 | 49.04 ± 11.05 | 49.75 ± 11.05 |
| Gender (n) | ||||
| Female | 86 | 64 | 57 | 30 |
| Male | 103 | 98 | 73 | 42 |
| Proteinuria (g/24 h) | – | 2.89 ± 0.67 | 4.01 ± 1.31# | 5.42 ± 1.75#& |
| Serum Albumin (g/L) | 48.24 ± 5.31 | 36.13 ± 6.01* | 27.33 ± 5.08*# | 19.76 ± 5.04*#& |
| BUN (mmol/L) | 4.68 ± 1.39 | 6.17 ± 2.11* | 6.48 ± 1.93* | 6.93 ± 1.75* |
| GFR (mL/min/1.73 m2) | 131.46 ± 12.71 | 80.65 ± 13.12* | 65.44 ± 10.97*# | 44.81 ± 11.26*#& |
| Total cholesterol (mmol/L) | 4.16 ± 1.13 | 6.27 ± 2.84* | 10.85 ± 3.09*# | 13.28 ± 5.22*#& |
| Tryglyeride(mmol/L) | 1.08 ± 0.36 | 1.59 ± 0.61* | 1.94 ± 0.56*# | 2.38 ± 0.55*#& |
| Scr (μmol/L) | 75.96 ± 13.45 | 93.42 ± 16.82* | 162.83 ± 25.14*# | 378.68 ± 57.91*#& |
BUN: blood urea nitrogen; GFR: glomerular filtration rate; Scr: serum creatinine.
*Compared with Healthy Control Group, the p values <.05.
#Compared with Stage I, the p values <.05.
&Compared with Stage II, the p values <.05.